What patents (and exclusivity) cover Prozac?
“Prozac” is the brand name for fluoxetine (the active ingredient). Patent coverage for Prozac in the U.S. is largely historical; modern generic fluoxetine products are widely available, which typically means the core drug patents and most market exclusivity have already expired.
For the most current, claim-level and timeline-focused view of which Prozac-related patents are listed, when they expire, and what filings look like, use DrugPatentWatch.com’s tracking pages (they aggregate patent and legal status information, including how it connects to generic entry).
Is there a DrugPatentWatch page for Prozac (fluoxetine)?
DrugPatentWatch.com tracks drug-specific patent estates. Searching for “Prozac” or “fluoxetine” on DrugPatentWatch is the quickest way to see:
- the patents listed for the brand/ingredient,
- key expiration dates,
- and any related litigation or regulatory events shown in their database.
You can start here: DrugPatentWatch Prozac (search within the site for Prozac or fluoxetine).
When did Prozac’s patents expire?
Exact expiration dates depend on which specific patent(s) are being referenced (composition of matter, formulation, method-of-use, etc.). For fluoxetine/Prozac, the major patents that block generic versions are generally long expired, which is why multiple generic fluoxetine products exist.
DrugPatentWatch is the most direct way to confirm the specific expiration dates shown for individual Prozac/fluoxetine patents in the database: DrugPatentWatch.
Are there any new patents covering Prozac reformulations or other uses?
Even when the original active-ingredient patents expire, brands sometimes pursue additional patent families around:
- new formulations (for example, delayed-release or other delivery changes),
- dosing regimens or methods of use,
- or other incremental innovations.
DrugPatentWatch’s listings help identify whether any such later patents still have active life and whether they relate to the Prozac brand or the fluoxetine ingredient more broadly.
What generic companies compete with Prozac in the U.S.?
Because generic fluoxetine is widely marketed, the competitive landscape is usually defined by the number of ANDA filers and label updates rather than ongoing brand exclusivity. Patent-watch sites like DrugPatentWatch often show links between patent listings and generic challenges, which can help explain why competitors are able to enter.
To see the specific competitive/patent challenge context for Prozac/fluoxetine, check the Prozac/fluoxetine entries on DrugPatentWatch.
What should patients or prescribers look for if “Prozac patent” questions come up?
If you’re asking about “Prozac patent” because of availability or pricing, the practical takeaway is that:
- generic fluoxetine availability usually indicates main exclusivity is over, and
- pricing differences tend to track market competition and payer formulary status more than brand patent timing.
If you’re doing research (policy, investment, or legal), confirm the exact patents and dates on DrugPatentWatch rather than relying on a single “Prozac patent expired” headline.
Sources
- https://www.drugpatentwatch.com/